The Reading Frame
Published in

The Reading Frame

COVID Patients Can’t Stop and Smell the Roses

A study of over 2,500 European patients has revealed that 85.9 percent of those with mild COVID-19 symptoms lost their sense of smell. On average, this olfactory dysfunction lingered for around three weeks. In a quarter of patients, their sense of smell was impaired for over two months.

The study, published in the Journal of Internal Medicine, was conducted by Jerome R. Lechien from…

--

--

--

The Reading Frame highlights breakthroughs at the leading edge of science, technology, and innovation.

Recommended from Medium

Another Wave, the Same Mistakes

Covid-19: Proof of Testing and Immunization … Work, Travel, Visit and more

Why the FDA’s Pfizer Hearing This Week Is So Important

A Moment of COVID, A Lifetime of Immune Protection?

Why UCU’s call on minimum ventilation standards is correct

Today’s World Controversial Bloodcurdling Eye-Opening Nailing News Byte

Scientists Develop Nasal Spray That Can Disable Coronavirus

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

More from Medium

Combating Cancer With Invisible Bacteria

Replacing Microglia to Slow Down Neurodegenerative Disease

What We Have To Be Aware About Cell Signalling

Why Mucus-Eating Bacteria Stimulate a Healthy Gut